Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The person must be female.
- The person must be between 45 and 75 years old at the time of enrolling in the study.
- The person must have been diagnosed with stage 1, 2, or 3 breast cancer between 5 and 10 years before enrolling in the study.
- The person must have received certain types of chemotherapy or radiation treatment, specifically: anthracycline (at any dose), OR trastuzumab (also known as Herceptin) for breast cancer with the HER2 gene mutation, OR tyrosine kinase inhibitors (such as sunitinib), OR radiotherapy to the left side of the chest.
- The person must have at least one traditional heart disease risk factor, such as high blood pressure, high cholesterol, diabetes, obesity, smoking, or a family history of heart disease.
- The person must currently be physically inactive, meaning they are not meeting Australian physical activity guidelines for adults and are not regularly doing structured exercise.
- The person must be eligible for Medicare.
- The person must be willing to sign a written consent form to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have already been diagnosed with cardiovascular disease (heart or blood vessel disease) or stage B heart failure.
- People who have been diagnosed with a brain or nervous system condition affecting thinking or memory, or a condition affecting blood flow to the brain.
- People who have been diagnosed with atrial fibrillation or any other irregular heart rhythm.
- People with a BMI of 18.4 or below (confirm with trial site).
- People for whom exercise testing or training would be considered unsafe based on medical screening.
- People who are not able to speak and understand English.
- People for whom a brain MRI scan is not safe or suitable (confirm with trial site).
- People who are already taking part in another clinical trial where being assigned to a different treatment group would be a problem.
- People with a life expectancy of 12 months or less due to cancer or any other medical condition, or people with any other medical condition — including pregnancy — where the lead researcher determines that joining the trial would not be appropriate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erin Howden, A/Professor, Baker Heart and Diabetes Institute
Phone: +61 38532 1861
Australian sites
613 8532 1709
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change from Baseline in Neurovascular Function Measured via MRI-Derived Total Cerebral Blood Flow at 6 Months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.